[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340951-105":59,"doc-detail-340951-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","autophagy-and-oxidative-stress-modulation-mediate-bortezomib-resistance-in-prostate-cancer","Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancer","","Proteasome inhibitors such as Bortezomib are established targeted therapies for hematological malignancies, yet resistance substantially limits their efficacy and solid-tumor responses remain under study. Using the prostate cancer DU-145 cell line, a Bortezomib-resistant model was generated and characterized for mechanisms including restored proteasome chymotrypsin-like activity, induction of pro-survival pathways, and autophagy-mediated compensation within proteostasis. Resistant clones also reduce Bortezomib-driven reactive oxygen species production to levels below non-resistant cells.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/autophagy-and-oxidative-stress-modulation-mediate-bortezomib-resistance-in-prostate-cancer/340951/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/autophagy-and-oxidative-stress-modulation-mediate-bortezomib-resistance-in-prostate-cancer/340951.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem limits Bortezomib therapy despite its targeted mechanism?","Question",{"text":112,"@type":113},"A major limitation is the emergence of resistance, which reduces efficacy and complicates responses in different cancer types.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was Bortezomib resistance modeled in this study?",{"text":117,"@type":113},"The study used the prostate cancer cell line DU-145 to establish a model of Bortezomib resistance and then evaluated the resistant cell line’s properties.",{"name":119,"@type":110,"acceptedAnswer":120},"Which biological changes were observed in the resistant clones?",{"text":121,"@type":113},"Resistant cells showed restored proteasome chymotrypsin-like activity independent of drug presence, induction of pro-survival pathways, autophagy-mediated substitution of proteostasis roles, and lower reactive oxygen species generation compared with non-resistant cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340951,1790198538,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","PLOS ONE  \nOPEN ACCESS  \nCitation: Zafeiropoulou K, Kalampounias G, Alexis S, Anastasopoulos D, Symeonidis A, Katsoris P (2024) Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancer. PLoS ONE 19(2): e0289904 . [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.1371/journal.pone](10.1371/journal.pone).0289904  \nEditor: Laila Adel Ziko, University of Hertfordshire hosted by Global Academic Foundation, EGYPT  \nReceived: July 27, 2023  \nAccepted: January 27, 2024  \nPublished: February 27, 2024  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here:  \n[https://doi.org/10.1371/journal.pone.0289904](https://doi.org/10.1371/journal.pone.0289904)  \n[Copyright:](Copyright:) © [2024 Zafeiropoulou](2024 Zafeiropoulou) et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData Availability Statement: All relevant data are within the manuscript and its Supporting Information files.  \nRESEARCH ARTICLE  \nAutophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancer  \nKalliopi Zafeiropoulou1,2☯, Georgios Kalampounias1☯, Spyridon Alexis2, Daniil Anastasopoulos1, Argiris Symeonidis2, Panagiotis Katsoris1 *  \n1 Division of Genetics, Cell Biology and Development, Department of Biology, University of Patras, Patras, Greece, 2 Hematology Division, Department of Internal Medicine, University of Patras Medical SchoolUniversity Hospital, Patras, Greece  \n☯ These authors contributed equally to this work.  \n* [katsopan@upatras.gr](katsopan@upatras.gr)  \nAbstract  \nProteasome inhibitors such as Bortezomib represent an established type of targeted treatment for several types of hematological malignancies, including multiple myeloma, Waldenstrom’s macroglobulinemia, and mantle cell lymphoma, based on the cancer cell’s susceptibility to impairment of the proteasome-ubiquitin system. However, a major problem limiting their efficacy is the emergence of resistance. Their application to solid tumors is currently being studied, while simultaneously, a wide spectrum of hematological cancers, such as Myelodysplastic Syndromes show minimal or no response to Bortezomib treatment. In this study, we utilize the prostate cancer cell line DU-145 to establish a model of Bortezomib resistance, studying the underlying mechanisms. Evaluating the resulting resistant cell line, we observed restoration of proteasome chymotrypsin-like activity, regardless of drug presence, an induction of pro-survival pathways, and the substitution of the Ubiquitin-Proteasome System role in proteostasis by induction of autophagy. Finally, an estimation of the oxidative condition of the cells indicated that the resistant clones reduce the generation of reactive oxygen species induced by Bortezomib to levels even lower than those induced in non-resistant cells. Our findings highlight the role of autophagy and oxidative stress regulation in Bortezomib resistance and elucidate key proteins of signaling pathways as potential pharmaceutical targets, which could increase the efficiency of proteasome-targeting therapies, thus expanding the group of molecular targets for neoplastic disorders.  \nIntroduction  \nThe ubiquitin–proteasome pathway is the most important intracellular proteolytic system, and the integrity of its function is crucial for cell homeostasis [ 1] . Proteasome substrates encompass signaling molecules, tumor suppressors, cell-cycle regulators, transcription factors, inhibitory molecules (whose degradation activates other proteins), and anti-apoptotic proteins (e.g., Bcl-2), among others [2] . When de","cbCaiuoHuYqX37FC","https://ap.wps.com/l/cbCaiuoHuYqX37FC","pdf",1609588,23,"English","# Abstract\n# Introduction","[{\"question\":\"What problem limits Bortezomib therapy despite its targeted mechanism?\",\"answer\":\"A major limitation is the emergence of resistance, which reduces efficacy and complicates responses in different cancer types.\"},{\"question\":\"How was Bortezomib resistance modeled in this study?\",\"answer\":\"The study used the prostate cancer cell line DU-145 to establish a model of Bortezomib resistance and then evaluated the resistant cell line’s properties.\"},{\"question\":\"Which biological changes were observed in the resistant clones?\",\"answer\":\"Resistant cells showed restored proteasome chymotrypsin-like activity independent of drug presence, induction of pro-survival pathways, autophagy-mediated substitution of proteostasis roles, and lower reactive oxygen species generation compared with non-resistant cells.\"}]","Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancer | PDF",1790039669,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a9b5d052366bdf0cdbfaf45a2274695.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99ced26b773207d0c66f0419d25072a8.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7e41e72a9d10ba60d6321b47096bb74.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e31349e73b00dd7d97557bce445d4852.webp",980,1268]